Letter: Intralesional P.P.D. in malignant melanoma

[Progress in epidemiological research of non-traditional risk factors for esophageal cancer].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2026

[Research progress on the lung cancer risk prediction models].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2025

[Research progress on the effect of influenza vaccination on chronic obstructive pulmonary disease].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2025

[Animal study on left bundle branch current of injury and anatomic location of leads in His-purkinje conduction system pacing].

Zhonghua xin xue guan bing za zhi·2023

Accelerating TB diagnosis during the COVID-19 pandemic.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022

Clinical standards for the diagnosis, treatment and prevention of TB infection.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

A giant intramuscular myolipoma of the gluteus maximus mimicking well-differentiated liposarcoma: a diagnostic challenge.

Journal of surgical case reports·2026

A Case of Primary Pulmonary Meningioma With Slow Enlargement Over a 9-Year Period.

Respirology case reports·2026

MuSK myasthenia gravis: from antigen-antibody to clinical translation.

Frontiers in immunology·2026

A multimodal complementary feature fusion network for myocardial pathological segmentation in multi-sequence cardiac magnetic resonance images.

Quantitative imaging in medicine and surgery·2026

A comparative analysis of MRI findings versus final pathology in multicentric breast cancer patients at King Abdulaziz Medical City, Jeddah.

Frontiers in surgery·2026

Case Report: Recurrent malignant phyllodes tumor with malignant peripheral nerve sheath tumor-like differentiation and loss of H3K27me3/RB1 expression.

Frontiers in oncology·2026

Related Experiment Videos

Letter: Intralesional P.P.D. in malignant melanoma

Related Concept Videos

[Progress in epidemiological research of non-traditional risk factors for esophageal cancer].

[Research progress on the lung cancer risk prediction models].

[Research progress on the effect of influenza vaccination on chronic obstructive pulmonary disease].

[Animal study on left bundle branch current of injury and anatomic location of leads in His-purkinje conduction system pacing].

Accelerating TB diagnosis during the COVID-19 pandemic.

Clinical standards for the diagnosis, treatment and prevention of TB infection.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

A giant intramuscular myolipoma of the gluteus maximus mimicking well-differentiated liposarcoma: a diagnostic challenge.

A Case of Primary Pulmonary Meningioma With Slow Enlargement Over a 9-Year Period.

MuSK myasthenia gravis: from antigen-antibody to clinical translation.

A multimodal complementary feature fusion network for myocardial pathological segmentation in multi-sequence cardiac magnetic resonance images.

A comparative analysis of MRI findings versus final pathology in multicentric breast cancer patients at King Abdulaziz Medical City, Jeddah.

Case Report: Recurrent malignant phyllodes tumor with malignant peripheral nerve sheath tumor-like differentiation and loss of H3K27me3/RB1 expression.

Related Experiment Videos

Letter: Intralesional P.P.D. in malignant melanoma

Related Concept Videos

Related Articles